Cite
HARVARD Citation
Schmalbrock, L. et al. (2018). Prognostic relevance of DNMT3A R882 mutations in AML patients undergoing non-myeloablative conditioning hematopoietic stem cell transplantation. Bone marrow transplantation. pp. 640-643. [Online].